Edition:
India

Akers Biosciences announces intention to explore strategic alternatives to maximize shareholder value


Wednesday, 7 Nov 2018 

Nov 7 (Reuters) - Akers Biosciences Inc ::AKERS BIOSCIENCES ANNOUNCES INTENTION TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE SHAREHOLDER VALUE.AKERS BIOSCIENCES INC - PROCESS WILL CONSIDER A RANGE OF POTENTIAL STRATEGIC ALTERNATIVES INCLUDING BUSINESS COMBINATIONS.AKERS BIOSCIENCES INC - EFFECTING A REVERSE STOCK SPLIT OF ITS ISSUED AND OUTSTANDING COMMON STOCK.AKERS BIOSCIENCES - DOES NOT PLAN TO DISCLOSE OR COMMENT ON DEVELOPMENTS REGARDING STRATEGIC REVIEW PROCESS UNTIL IT IS COMPLETE.AKERS BIOSCIENCES INC - REVERSE STOCK SPLIT STOCK OF 1 SHARE OF COMMON STOCK FOR EVERY 8 SHARES OF COMMON STOCK ON NOV 8, 2018. 

Company Quote

0.43
 --
19 Jul 2019